Tacrolimus
Tacrolimus
Definition
A macrolide isolated from Streptomyces tsukubaensis. Tacrolimus binds to the FKBP-12 protein and forms a complex with calcium-dependent proteins, thereby inhibiting calcineurin phosphatase activity and resulting in decreased cytokine production. This agent exhibits potent immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation. Tacrolimus possesses similar immunosuppressive properties to cyclosporine, but is more potent.
Also known as FK 506, FK-506, FK506, Fujimycin, Hecoria, Hexadecahydro-5,19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone, Prograf, Protopic, Tacforius, TACROLIMUS — per NCIT
Also identified as
- ATC D11AH per NCIT
- ATC L04AD per NCIT
- NCIT NCIT:C1311 per NCIT
Indications
| Disease | Relation | Source |
|---|---|---|
| Graft versus host disease | may prevent | MEDRT · Public domain (U.S. Government work) |
| Atopic eczema | may treat | MEDRT · Public domain (U.S. Government work) |
| Graft versus host disease | may treat | MEDRT · Public domain (U.S. Government work) |
Organ Effects
| Organ | Side effect / interaction | Source |
|---|---|---|
| Skin of body | may treat a disease of this organ | DERIVED · CC BY 4.0 |
1 entry above is marked DERIVED: Atlas Médico inferred it by combining two sourced claims, and no source asserts this link directly. Treat it as a navigation aid, not as a clinical statement.